Regulation of CD4 T‐cell receptor diversity by vaccine adjuvants
- 6 April 2010
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 130 (1), 16-22
- https://doi.org/10.1111/j.1365-2567.2010.03265.x
Abstract
New vaccines based on soluble recombinant antigens (Ags) require adjuvants to elicit long-lasting protective humoral and cellular immunity. Despite the importance of CD4 T helper cells for the generation of long-lived memory B and CD8 T cells, the impact of adjuvants on CD4 T-cell responses is still poorly understood. Adjuvants are known to promote dendritic cell (DC) maturation and migration to secondary lymphoid organs where they present foreign peptides bound to class II major histocompatibility complex molecules (pMHCII) to naïve CD4 T cells. Random and imprecise rearrangements of genetic elements during thymic development ensure that a vast amount of T-cell receptors (TCRs) are present in the naïve CD4 T-cell repertoire. Ag-specific CD4 T cells are selected from this vast pre-immune repertoire based on the affinity of their TCR for pMHCII. Here, we review the evidence demonstrating a link between the adjuvant and the specificity and clonotypic diversity of the CD4 T-cell response, and consider the potential mechanisms at play.Keywords
This publication has 66 references indexed in Scilit:
- Functional implications of T cell receptor diversityCurrent Opinion in Immunology, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responsesNature Immunology, 2009
- Mechanism of action of clinically approved adjuvantsCurrent Opinion in Immunology, 2009
- Migratory and Lymphoid-Resident Dendritic Cells Cooperate to Efficiently Prime Naive CD4 T cellsImmunity, 2008
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvantCellular and Molecular Life Sciences, 2008
- Vaccine Adjuvants Alter TCR-Based Selection ThresholdsImmunity, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsThe Journal of Experimental Medicine, 2008
- Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activationProceedings of the National Academy of Sciences of the United States of America, 2007
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007